#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4326431	Binding	Inhibition of full length human p110alpha/p85alpha using PIP2 as substrate after 30 mins by TR-FRET assay	Homo sapiens	2	ALA4325835	protein complex format	Scientific Literature
2.	ALA4326432	Binding	Inhibition of full length human His-tagged p110beta/p85alpha using PIP2 as substrate after 30 mins by TR-FRET assay	Homo sapiens	2	ALA4325835	protein complex format	Scientific Literature
3.	ALA4326433	Binding	Inhibition of full length human p110delta/p85alpha using PIP2 as substrate after 30 mins by TR-FRET assay	Homo sapiens	2	ALA4325835	protein complex format	Scientific Literature
4.	ALA4326434	Binding	Inhibition of full length human PI3Kgamma using PIP2 as substrate after 30 mins by TR-FRET assay	Homo sapiens	2	ALA4325835	single protein format	Scientific Literature
5.	ALA4326435	ADME	Intrinsic clearance in human hepatocytes at 0.5 uM measured up to 250 mins by UHPLC-HRMS based assay	Homo sapiens	1	ALA4325835	cell-based format	Scientific Literature
6.	ALA4326436	ADME	Intrinsic clearance in human liver microsomes at 1 uM measured in presence of NADPH/UDPGA by UHPLC-HRMS based assay	Homo sapiens	1	ALA4325835	microsome format	Scientific Literature
7.	ALA4326437	ADME	Drug metabolism in human hepatocytes assessed as AO-mediated fraction metabolized by measuring half life with and without hydralazine at 0.5 uM measured up to 250 mins by UHPLC-HRMS based assay	Homo sapiens	1	ALA4325835	cell-based format	Scientific Literature
8.	ALA4326438	ADME	Drug metabolism in human hepatocytes assessed as AO-mediated 4-(6-(2-amino-3-fluoropyridin-4-yl)-2-methyl-4-(4H-1,2,4-triazol-3-yl)-1H-benzo[d]imidazol-1-yl)-5,8-difluoroquinolin-2(1H)-one metabolite formation at 0.5 uM measured up to 250 mins by UHPLC-HRMS based assay	Homo sapiens	1	ALA4325835	cell-based format	Scientific Literature
9.	ALA4326439	ADME	Drug metabolism in human hepatocytes assessed as AO-mediated triazole oxidation at 0.5 uM measured up to 250 mins by UHPLC-HRMS based assay	Homo sapiens	1	ALA4325835	cell-based format	Scientific Literature
10.	ALA4326441	ADME	Drug metabolism in human liver cytosol assessed as AO-mediated 4-(6-(2-amino-3-fluoropyridin-4-yl)-2-methyl-4-(4H-1,2,4-triazol-3-yl)-1H-benzo[d]imidazol-1-yl)-5,8-difluoroquinolin-2(1H)-one metabolite formation at 0.5 uM measured after 2 hrs by UHPLC-HRMS based assay	Homo sapiens	1	ALA4325835	subcellular format	Scientific Literature
11.	ALA4326442	Binding	Inhibition of human ERG at 25 uM	Homo sapiens	1	ALA4325835	single protein format	Scientific Literature
12.	ALA4326443	ADME	Inhibition of human CYP450 at 25 uM	Homo sapiens	1	ALA4325835	protein format	Scientific Literature
13.	ALA4326444	ADME	Fraction unbound in Sprague-Dawley rat plasma	Rattus norvegicus	1	ALA4325835	cell-free format	Scientific Literature
14.	ALA4326445	ADME	Clearance in Sprague-Dawley rat at 1 mg/kg, iv by ESI-LC/MS/MS analysis	Rattus norvegicus	1	ALA4325835	organism-based format	Scientific Literature
15.	ALA4326446	ADME	Volume of distribution at steady state in Sprague-Dawley rat at 1 mg/kg, iv by ESI-LC/MS/MS analysis	Rattus norvegicus	1	ALA4325835	organism-based format	Scientific Literature
16.	ALA4326447	ADME	Terminal half life in Sprague-Dawley rat at 1 mg/kg, iv by ESI-LC/MS/MS analysis	Rattus norvegicus	1	ALA4325835	organism-based format	Scientific Literature
17.	ALA4326448	ADME	MRT in Sprague-Dawley rat at 1 mg/kg, iv by ESI-LC/MS/MS analysis	Rattus norvegicus	1	ALA4325835	organism-based format	Scientific Literature
18.	ALA4326449	ADME	Oral bioavailability in Sprague-Dawley rat at 5 mg/kg by ESI-LC/MS/MS analysis	Rattus norvegicus	1	ALA4325835	organism-based format	Scientific Literature
19.	ALA4326450	ADME	Fraction unbound in Beagle dog plasma	Canis lupus familiaris	1	ALA4325835	cell-free format	Scientific Literature
20.	ALA4326451	ADME	Clearance in Beagle dog at 1 mg/kg, iv by ESI-LC/MS/MS analysis	Canis lupus familiaris	1	ALA4325835	organism-based format	Scientific Literature